Comprehensive clinical review of recent FDA approvals including Darolutamide, Pluvicto, and AKEEGA, alongside evidence from PSMAfore, RADIOSA, and EXTEND trials.
Official invitation, factsheet, and scientific timetable for the Saudi GU multidisciplinary consensus sessions on June 17, 2025 in Riyadh.
Official proceedings and expert panel registry outlining standardized national referral pathways, hematuria rapid-access clinics, and the action roadmap.
Official publication release of the peer-reviewed clinical guidelines covering NMIBC risk stratification, BCG protocols, and systemic EV-pembrolizumab.
Official publication release of evidence-based consensus covering localized risk groups, SBRT margin reductions, ADT intensification, and mCRPC theranostics.